REG - UBS ETFs - UBS ETF, SICAV – Notice to Shareholders – AGM
RNS Number : 1053SUBS ETFs15 March 2021UBS ETF
Société d'Investissement à Capital Variable (SICAV)
Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg
R.C.S. Luxembourg: no. B 83626
ANNUAL GENERAL MEETING
Notice is hereby given to the shareholders of UBS ETF (the "Company") that the ANNUAL GENERAL MEETING of the shareholders of the Company will be held at the registered office of the Company at 49, avenue J.F. Kennedy, L-1855 Luxembourg on 15 April 2021 at 11.30 a.m. with the following agenda:
AGENDA
1. Presentation and approval of the Reports of the Board of Directors and of the Independent Auditors;
2. Approval of the Financial Statements for the accounting year ended 31 December 2020;
3. Allocation of the results and approval of the dividend distributions by the Company;
4. Discharge to the Board of Directors in relation to the performance of their duties during the accounting year ended 31 December 2020;
5. Statutory Elections:
i. Re-election of Mr. JESSEN Jorgen as Independent Director until the annual general meeting of shareholders to be held in 2024;
ii. Re-election of Mr. ASHMENT Ian as Director until the annual general meeting of shareholders to be held in 2025;
iii. Appointment of Mrs. BOHNEN Anja-Isabel as Independent Director until the annual general meeting of shareholders to be held in 2023;
iv. Appointment of Ernst & Young Services S.A. as Independent Auditor of the Company until the next annual general meeting of shareholders to the held in 2022;
6. Miscellaneous.
Copies of the latest version of the Annual Report are available free of charge during normal office hours at the registered office of the Company in Luxembourg or on the Internet website of the Company (www.ubs.com/etf) as of April 2nd, 2021.
For shareholders who are holding shares in the Company through a financial intermediary or clearing agent e. g. the bank where they safekeep their shareholding, it should be noted that:
- the proxy form must be returned to the financial intermediary or clearing agent e.g.. the bank where they safekeep their shareholding in good time for onward transmission to the Company by April 12, 2021.
There will be no requirement as to the quorum in order for the general meeting to validly deliberate and decide on the matters listed in the agenda; resolutions will be passed by the simple majority of the shares present or represented at the meeting. At the annual shareholders' meeting, each share entitles to one vote.
The majority at the AGM will be determined according to the shares issued and outstanding at midnight (Luxembourg time) on the fifth day prior to the AGM (i.e. April 9, 2021) (the "Record Date"). The rights of a shareholder to participate at the AGM and to exercise a voting right attaching to his/her/its shares are determined in accordance with the shares held by this shareholder at the Record Date.
Due to the exceptional circumstances of the Coronavirus COVID-19 and the measures taken by the Luxembourg government, shareholders who would like to participate to the General Meeting are required to do so by completing and signing either the voting form or the proxy form enclosed for your convenience.
No in-person attendance to the Annual General Meeting is possible.
Only those shareholders who are holding their shares by being directly registered in the Company´s share register should send either the enclosed Form of Proxy or Voting Form by e-mail to Luxembourg-Domiciliarygroup@statestreet.com and/or by fax to +352 46 40 10 413 no later than 13 April 2021 close of business in Luxembourg.
The original Form of Proxy or Voting Form as applicable shall then be sent by mail to the registered office of the Company (Attn. Domiciliary Services).
Proxy forms and Voting forms may be obtained by simple request at the same address.
Luxembourg, March 15, 2021
By Order of the Board of Directors
UBS ETF
Société d'Investissement à Capital Variable (SICAV)
Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg
R.C.S. Luxembourg: no. B 83626
FORM OF PROXY
I/we ________________________the undersigned,
herewith give proxy for _____________________ /all my/our shares of
UBS ETF (the "Company")
to the Chairman of the shareholders' meeting with full power of substitution to exercise on my/our behalf the voting rights relating to my/our shares at the Annual General Meeting of the shareholders of UBS ETF to be held in Luxembourg on 15 April 2021 at 11.30 a.m. (Luxembourg time) and at any meeting to be held thereafter for the same purpose, with the same agenda, to act and vote on the matters set out in the following agenda:
AGENDA
1. FOR ¥ AGAINST ¥ Presentation and approval of the Reports of the Board of Directors
ABSTAIN ¥ and of the Independent Auditors;
2. FOR ¥ AGAINST ¥
ABSTAIN Approval of the Financial Statements for the accounting year ended
31 December 2020;
3. FOR ¥ AGAINST ¥
ABSTAIN Allocation of the results and approval of the dividend distributions by the Company;
4. FOR ¥ AGAINST ¥
ABSTAIN Discharge to the Board of Directors in relation to the performance of their duties during the accounting year ended 31 December 2020;
5 i. FOR ¥ AGAINST ¥
ABSTAIN Re-election of Mr. JESSEN Jorgen as Independent Director until the annual general meeting of shareholders to be held in 2024;
5 ii. FOR ¥ AGAINST ¥
ABSTAIN Re-election of Mr. ASHMENT Ian as Director until the annual general meeting of shareholders to be held in 2025;
5 iii. FOR ¥ AGAINST ¥
ABSTAIN Appointment of Mrs. BOHNEN Anja-Isabel as Independent Director until the annual general meeting of shareholders to be held in 2023;
5 iv. FOR ¥ AGAINST ¥
ABSTAIN Appointment of Ernst & Young Services S.A. as Independent Auditor of the Company until the next annual general meeting of shareholders to be held in 2022.
I/we hereby give and grant full power and authorization to do and perform all and everything necessary or incidental to the exercise of the powers herein specified and we hereby ratify and confirm that said proxy shall lawfully do or cause to be done by virtue hereof.
Signed: Date:
UBS ETF
Société d'Investissement à Capital Variable (SICAV)
Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg
R.C.S. Luxembourg: no. B 83626
VOTING FORM
The undersigned_,------------------------------------------------------------
Holder of__---------------------------------------------------_ shares of
UBS ETF (the "Company")
Hereby declares that he/she/ it is not attending in person to the Annual General Meeting of the shareholders of UBS ETF to be held in Luxembourg on 15 April 2021 at 11.30 a.m (Luxembourg time) and at any meeting to be held thereafter for the same purpose, with the following agenda:
AGENDA
1. Presentation and approval of the Reports of the Board of Directors and of the Independent Auditors;
2. Approval of the Financial Statements for the accounting year ended 31 December 2020;
3. Allocation of the results and approval of the dividend distributions by the Company;
4. Discharge to the Board of Directors in relation to the performance of their duties during the accounting year ended 31 December 2020;
5. Statutory Elections:
i. Re-election of Mr. JESSEN Jorgen as Independent Director until the annual general meeting of shareholders to be held in 2024;
ii. Re-election of Mr. ASHMENT Ian as Director until the annual general meeting of shareholders to be held in 2025;
iii. Appointment of Mrs. BOHNEN Anja-Isabel as Independent Director until the annual general meeting of shareholders to be held in 2023;
iv. Appointment of Ernst & Young Services S.A. as Independent Auditor of the Company until the next annual general meeting of shareholders to the held in 2022;
6. Miscellaneous.
The undersigned hereby votes as follow on the proposed resolutions of the Annual General Meeting of the shareholders:
1. Presentation and approval of the Reports of the Board of Directors and of the Independent Auditors:
FOR AGAINST ABSTAIN
2. Approval of the Financial Statements for the accounting year ended 31 December 2020:
FOR AGAINST ABSTAIN
3. Allocation of the results and approval of the dividend distributions by the Company:
FOR AGAINST ABSTAIN
4. Discharge to the Board of Directors in relation to the performance of their duties during the accounting year ended 31 December 2020:
FOR AGAINST ABSTAIN
5. Statutory Elections
5.i. Re-election of Mr. JESSEN Jorgen as Independent Director until the annual general meeting of shareholders to be held in 2024:
FOR AGAINST ABSTAIN
5.ii Re-election of Mr. ASHMENT Ian as Director until the annual general meeting of shareholders to be held in 2025:
FOR AGAINST ABSTAIN
5.iii Appointment of Mrs. BOHNEN Anja-Isabel as Independent Director until the annual general meeting of shareholders to be held in 2023:
FOR AGAINST ABSTAIN
5.iv Appointment of Ernst & Young Services S.A. as Independent Auditor of the Company until the next annual general meeting of shareholders to the held in 2022:
FOR AGAINST ABSTAIN
6. Miscellaneous.
FOR AGAINST ABSTAIN
Signed: Date:
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDNOAFLFFIVEIFLIL
Recent news on CS SA
See all newsREG - UBS ETFs - UBS (Lux) Fund Solutions – Notice to Shareholders
AnnouncementREG - Credit Suisse Intl Credit Suisse, AG Credit Suisse Intl - Post Stab Notice CS Group EUR3bln Sen Nts 2029
AnnouncementREG - Natixis Structured - Half-year Report
AnnouncementREG - Natixis Structured - Annual Financial Report
AnnouncementRCS - EIG Pearl Holdings - 1st Quarter Results
Announcement